Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Titan Biotech Ltd.

May 18 BSE 499.85 ( -7.40 -1.46%)

Volume4533

Prev. Close
507.25

Open Price
508.00

Today's Low / High

492.70 515.85

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

230.00 618.00

Titan Biotech Ltd.is not traded in NSE

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	82.64	82.64	82.64	82.64	82.64

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	8.26	8.26	8.26	8.26	8.26
Total Share Capital	8.26	8.26	8.26	8.26	8.26

Reserves and Surplus	101.65	90.40	60.49	30.93	23.91
Total Reserves and Surplus	101.65	90.40	60.49	30.93	23.91
Total Shareholders Funds	109.91	98.67	68.76	39.19	32.18
Minority Interest	0.00	6.74	3.72	2.35	1.58

NON-CURRENT LIABILITIES
Long Term Borrowings	0.30	8.40	4.86	11.55	13.17
Deferred Tax Liabilities [Net]	1.21	1.31	1.39	1.23	1.05
Other Long Term Liabilities	1.13	1.55	1.40	0.00	0.00
Long Term Provisions	1.62	1.51	1.49	1.28	0.98
Total Non-Current Liabilities	4.25	12.76	9.13	14.06	15.19

CURRENT LIABILITIES
Short Term Borrowings	6.70	7.47	8.29	11.34	9.68
Trade Payables	5.55	7.55	3.71	4.12	2.14
Other Current Liabilities	7.77	9.92	7.11	4.97	3.96
Short Term Provisions	0.33	0.29	0.00	0.00	0.00
Total Current Liabilities	20.35	25.23	19.11	20.43	15.78

Total Capital And Liabilities	134.52	143.40	100.72	76.04	64.73

ASSETS
NON-CURRENT ASSETS
Tangible Assets	35.81	42.05	33.51	31.06	28.92
Intangible Assets	0.09	0.10	0.09	0.10	0.09
Capital Work-In-Progress	13.29	7.97	0.27	0.07	0.00
Fixed Assets	49.19	50.12	33.88	31.23	29.02
Non-Current Investments	15.41	0.00	0.00	0.00	0.00
Other Non-Current Assets	1.62	1.93	7.51	0.61	0.58
Total Non-Current Assets	66.21	52.05	41.39	31.84	29.59


CURRENT ASSETS
Inventories	36.17	42.29	32.54	27.98	21.13
Trade Receivables	21.01	21.67	18.10	11.86	9.24
Cash And Cash Equivalents	4.86	15.61	5.63	1.86	2.04
OtherCurrentAssets	6.26	11.78	3.05	2.50	2.72
Total Current Assets	68.31	91.35	59.33	44.20	35.14

Total Assets	134.52	143.40	100.72	76.04	64.73

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1.13	3.20	0.38	0.00	0.00

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	15.41	0.00	0.00	0.00	0.00

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	82.64

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	8.26
Total Share Capital	8.26
Reserves and Surplus	101.65
Total Reserves and Surplus	101.65
Total Shareholders Funds	109.91
Minority Interest	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	0.30
Deferred Tax Liabilities [Net]	1.21
Other Long Term Liabilities	1.13
Long Term Provisions	1.62
Total Non-Current Liabilities	4.25
CURRENT LIABILITIES
Short Term Borrowings	6.70
Trade Payables	5.55
Other Current Liabilities	7.77
Short Term Provisions	0.33
Total Current Liabilities	20.35
Total Capital And Liabilities	134.52
ASSETS
NON-CURRENT ASSETS
Tangible Assets	35.81
Intangible Assets	0.09
Capital Work-In-Progress	13.29
Fixed Assets	49.19
Non-Current Investments	15.41
Other Non-Current Assets	1.62
Total Non-Current Assets	66.21
CURRENT ASSETS
Inventories	36.17
Trade Receivables	21.01
Cash And Cash Equivalents	4.86
OtherCurrentAssets	6.26
Total Current Assets	68.31
Total Assets	134.52
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1.13
NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	15.41